M
Michelle Turner
Researcher at University of Utah
Publications - 15
Citations - 1968
Michelle Turner is an academic researcher from University of Utah. The author has contributed to research in topics: Heart catheterization & Pulmonary hypertension. The author has an hindex of 8, co-authored 14 publications receiving 1710 citations.
Papers
More filters
Journal ArticleDOI
Pulmonary Arterial Hypertension : Baseline Characteristics From the REVEAL Registry
David B. Badesch,Gary E. Raskob,C. Greg Elliott,Abby M. Krichman,Harrison W. Farber,Adaani E. Frost,Robyn J. Barst,Raymond L. Benza,Theodore G. Liou,Michelle Turner,Scott Giles,K. Feldkircher,Dave P. Miller,Michael D. McGoon +13 more
TL;DR: Compared with patients meeting the traditional hemodynamic definition of PAH, patients with a PCWP of 16 to 18 mm Hg were older, more obese, had a lower 6-min walk distance, and had a higher incidence of systemic hypertension, sleep apnea, renal insufficiency, and diabetes.
Journal ArticleDOI
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
Adaani E. Frost,David B. Badesch,Robyn J. Barst,Raymond L. Benza,C. Gregory Elliott,Harrison W. Farber,Abby M. Krichman,Theodore G. Liou,Gary E. Raskob,P. Wason,Kathleen Feldkircher,Michelle Turner,Michael D. McGoon +12 more
TL;DR: There was a striking preponderance of women, and REVEAL patients were more likely to be obese, compared with NIH and contemporary European and UK registries, and the difference in HIV-associated PAH between REVEal and other non-US contemporary registries warrant further investigation.
Journal ArticleDOI
Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry.
Lynette M. Brown,Lynette M. Brown,Hubert Chen,Scott D. Halpern,Darren B. Taichman,Michael D. McGoon,Harrison W. Farber,Adaani E. Frost,Theodore G. Liou,Michelle Turner,K. Feldkircher,Dave P. Miller,C. Gregory Elliott,C. Gregory Elliott +13 more
TL;DR: In this paper, the authors investigated factors associated with a prolonged symptomatic period before the recognition of Pulmonary Arterial Hypertension (PAH) and found that younger individuals and patients with histories of common respiratory disorders were more likely to experience delayed PAH recognition.
Journal ArticleDOI
Sex Differences in the Diagnosis, Treatment, and Outcome of Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management
TL;DR: Findings highlight similarities and differences between men and women with PAH, raising questions for future exploration regarding the role of hormones and sex in causation and survival in PAH.
Journal ArticleDOI
Comorbid Conditions and Outcomes in Patients With Pulmonary Arterial Hypertension: A REVEAL Registry Analysis
TL;DR: Compared with other analyzed comorbidities in patients with PAH, hypertension, obesity, diabetes, and COPd were associated with significantly worse 6MWD; obesity and COPD were associatedWith worse FC; and diabetes and COPS were associatedwith increased risk for death.